TOE

3.92%

26.5¢ toro energy limited

Ann: Updated Scoping Study Results Lake Maitland Uranium Project, page-104

First 104 Last

Share
Profile

Follow
Mikesmith1981

772 Posts.

114

21/06/24

09:17

Post #: 74418754
Share

Originally posted by Rubiconis: ↑

I don't follow cricket so not sure what you blabbing about there.

Anyway, I am pretty sure at the time, the performance rights, way out of the money, were cancelled. They lapsed, without a swap for DYL shares. The agreement made an allowance for it, concurrent with schedule 2. From memory, there was a 2-part section for the treatment of lapsed unlisted options. But, I may be wrong.

Regardless, your contention that it was the lack of financial incentive that led to RH's poor performance is disturbing. Especially considering that over time he has sold down his once substantial private holding to essentially zero.

And further, while you say to this forum that the stock at these prices is cheap and a great buy, your fearless leader has not bought a single share, and has no plans to do so. What does that tell you? Can you think why a director would sell down his entire holding? And then refuse to buy, even at all time lows?

Doesn't take a genius to figure it out. It's called... "a permitless uranium project, under a uranium mining ban, with Labour-Green alliance about to get re-elected again". RH is many things, but stupid, he ain't.

Expand

I didn't do my research well enough. Turns out subsequent to last annual report he added 1m shares

https://www.marketindex.com.au/asx/directors/richard-homsany

Last edited by Mikesmith1981: 21/06/24

TOE Price at posting: 35.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 104 Last

Add TOE (ASX) to my watchlist

(20min delay)
Last 26.5¢		Change 0.010(3.92%)		Mkt cap ! $31.87M

Open	High	Low	Value	Volume
26.0¢	27.5¢	26.0¢	$111.3K	422.3K

Buyers (Bids)

No.	Vol.	Price($)
1	6098	26.5¢

Sellers (Offers)

Price($)	Vol.	No.
27.0¢	3700	1

View Market Depth

No.	Vol.	Price($)
3	60326	0.260
3	48499	0.255
6	53306	0.250
2	50816	0.245
1	40000	0.240

Price($)	Vol.	No.
0.270	3700	1
0.275	8370	1
0.280	8700	1
0.285	44400	3
0.290	28485	4

Last trade - 16.10pm 15/11/2024 (20 minute delay)

TOE (ASX) Chart

Ann: Updated Scoping Study Results Lake Maitland Uranium Project, page-104

Banshee's historic trenches prove rich in antimony and gold for GDM

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Updated Scoping Study Results Lake Maitland Uranium Project, page-104

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News